Celularity Inc. Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions
Celularity Inc. (CELU) reported Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-07-30.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions · last filed 2024-07-30
- Celularity Inc. unrecognized tax benefits, decrease resulting from current period tax positions for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Celularity Inc. unrecognized tax benefits, decrease resulting from current period tax positions for fiscal 2022 was $242.00K.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-07-30 |
| 2022-12-31 | $242.00K 10-K · filed 2024-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |